Sales of Chemours’ Opteon refrigerants up 14% in 2024
19th February 2025
USA: Chemours saw sales of its Opteon brand HFO refrigerants and lower GWP HFC/HFO blends grow 14% in 2024 to $810m.
This was bolstered by a 23% year-on-year growth in Q4 in advance of the new low GWP stationary air conditioning equipment transition started this year under the US AIM Act.
Meanwhile, Chemours legacy Freon brand gases, which include R134a and R410A, were down 15% for the year at $614m. Chemours attributes much of this to a decrease in pricing due to elevated market inventory levels.
A major feature of 2024 was the completion of an expansion of Chemours HFO1234yf production facility at Corpus Christi, Texas.
In all, Chemours’ Thermal & Specialised Solutions (TSS) business saw adjusted EBITDA decrease 16% to $576m compared to the prior year. Chemours primarily blames the softer Freon refrigerant prices, higher costs associated with purchasing non-Corpus-based low GWP refrigerant, near-term quota allowances, lower fixed cost absorption in TSS’s HFC production line and other input costs.
Chemours total net sales for the year were $5,782m down 5% on 2023.
